Saheed Olanrewaju Afolabi et al. 2022. Combined Intranasal Insulin/Saxagliptin/Metformin Therapies Ameliorates the Effect of Combined Oral Contraceptives (Cos)-Induced Metabolic Syndrome (MetS) with a Major Target on Glucose Metabolism in Adult Female Wistar Rats: A Recent Study. New Horizons in Medicine and Medical Research Vol. 12. (Jun. 2022), 91–107. DOI:https://doi.org/10.9734/bpi/nhmmr/v12/6111F.